Zusammenfassung
Herzinsuffizienz im Kindesalter betrifft am häufigsten Säuglinge mit angeborenen Herzfehlern, die eine Volumenbelastung hervorrufen. Während diese durch operative oder interventionelle Behandlung kausal frühzeitig beseitigt werden kann, erfordert die Herzinsuffizienz vor allem bei nur palliativ behandelten Herzfehlern im Langzeitverlauf ebenso wie bei Kardiomyopathien eine medikamentöse Therapie. Wenngleich die wissenschaftlichen Daten für eine evidenzbasierte Therapie im Vergleich zum Erwachsenenalter erheblich geringer sind, stellt das Kapitel die verfügbaren Informationen über die Behandlung sowohl der chronischen als auch der akuten Herzinsuffizienz prägnant dar.
Notes
- 1.
Umrechnung: g/dl × 0,62 = mmol/l.
Weiterführende Literatur
Buchhorn R, Hulpke-Wette M et al (2001) Propranolol treatment of congestive heart failure in infants with congenital heart disease: the CHF-PRO-INFANT trial. Int J Cardiol 79:176–183
Canter CE, Shaddy RE, Bernstein D et al (2007) Indications for heart transplantation in pediatric heart disease: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 115(5):658–676
Cantinotti M, Law Y, Vittorini S, Crocetti M, Marco M, Murzi B, Clerico A (2014) The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update. Heart Fail Rev 19(6):727–742
Dubin AM, Janousek J, Rhee E et al (2005) Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study. J Am Coll Cardiol 46(12):2277–2283
Elkayam U, Janmohamed M, Habib M, Hatamizadeh P (2008) Vasodilators in the management of acute heart failure. Crit Care Med 36(1 Suppl):95–105
Fisher DG, Schwartz PH, Davis AL (1993) Pharmacokinetics of exogenous epinephrine in critically ill children. Crit Care Med 21:111–117
Geiger R, Strasak A, Treml B, Gasser K, Kleinsasser A, Fischer V, Geiger H, Loeckinger A, Stein JI (2007) Six-minute walk test in children and adolescents. J Pediatr 150:395–399
Gnanappa GK, Celermajer DS, Sholler GF, Gentles T, Winlaw D, d’Udekem Y, Ayer J (2017) The long-term management of children and adults with a Fontan circulation: a systematic review and survey of current practice in Australia and New Zealand. Pediatr Cardiol 38(1):56–69
Habib DM, Padbury JF, Anas NG, Perkin RM, Minegar C (1992) Dobutamine pharmacokinetics and pharmacodynamics in pediatric intensive care patients. Crit Care Med 20:601–608
Hammer GB, Lewandowski A, Drover DR, Rosen DA, Cohane C, Anand R, Mitchell J, Reece T, Schulman SR (2015) Safety and efficacy of sodium nitroprusside during prolonged infusion in pediatric patients. Pediatr Crit Care Med 16(5):397–403
Hoffman TM, Wernovsky G, Atz AM et al (2003) Efficacy and safety of milrinone in preventing low cardiac output in infants and children after corrective surgery for congenital heart disease. Circulation 107:996–1002
Hsu DT, Pearson GD, Hsu DT, Pearson GD (2009) Heart failure in children: part II: diagnosis, treatment, and future directions. Circ Heart Fail 2(5):490–498
Hsu DT, Zak V, Mahony L, Sleeper LA, Atz AM, Levine JC, Barker PC, Ravishankar C, McCrindle BW, Williams RV, Altmann K, Ghanayem NS, Margossian R, Chung WK, Border WL, Pearson GD, Stylianou MP, Mital S, Pediatric Heart Network Investigators (2010) Enalapril in infants with single ventricle: results of a multicenter randomized trial. Circulation 122(4):333–340
Hummel J, Rücker G, Stiller B (2017) Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease. Cochrane Database Syst Rev (8):CD011312
Janousek J, Gebauer RA, Abdul-Khaliq H et al (2009) Cardiac resynchronisation therapy in paediatric and congenital heart disease: differential effects in various anatomical and functional substrates. Heart 95:1165–1171
Kantor PF, Lougheed J, Dancea A, McGillion M, Barbosa N, Chan C, Dillenburg R, Atallah J, Buchholz H, Chant-Gambacort C, Conway J, Gardin L, George K, Greenway S, Human DG, Jeewa A, Price JF, Ross RD, Roche SL, Ryerson L, Soni R, Wilson J, Wong K, Children’s Heart Failure Study Group (2013) Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines. Can J Cardiol 29(12):1535–1552
Krum H, Teerlink JR (2011) Medical therapy for chronic heart failure. Lancet 378(9792):713–721
Miera O, Dähnert I, Haas N, Hirt MN, Thul J Akute Herzinsuffizienz und Ventrikulärer Assist Device(VAD)/Extrakorporale Membranoxygenierung (ECMO) Leitlinien zur rationalen Diagnostik und Therapie von Erkrankungen des Herzens und des Kreislaufs bei Kindern und Jugendlichen, S 25–32
Momma K (2006) ACE inhibitors in pediatric patients with heart failure. Paediatr Drugs 8(1):55–69
Mori Y, Nakazawa M, Tomimatsu H, Momma K (2000) Longterm effect of angiotensin-converting enzyme inhibitor in volume overloaded heart during growth: a controlled pilot study. J Am Coll Cardiol 36:270–275
Nadas AS (2006) Hypoxemia. In: Keane JF, Fyler DC, Lock JE (Hrsg) Nadas’ pediatric cardiology, 2. Aufl. Hanley & Belfus, Philadelphia, S 73–76
Patel AR, Shaddy RE (2010) Role of β-blocker therapy in pediatric heart failure. Ped Health 4:45–58
Rickers C, Läer S, Diller GP, Janousek J, Hoppe U, Mir TS, Weil J (2015) Chronische Herzinsuffizienz im Kindesalter. In: Deutsche Gesellschaft für Pädiatrische Kardiologie (Hrsg) Leitlinien zur rationalen Diagnostik und Therapie von Erkrankungen des Herzens und des Kreislaufs bei Kindern und Jugendlichen. Urban & Fischer, München, S 33–40
Roche SL, Timberlake K, Manlhiot C, Balasingam M, Wilson J, George K, McCrindle BW, Kantor PF (2016) Angiotensin-converting enzyme inhibitor initiation and dose uptitration in children with cardiovascular disease: a retrospective review of standard clinical practice and a prospective randomized clinical trial. J Am Heart Assoc 5(5):e003230
Roeleveld PP, de Klerk JCA (2018) The perspective of the intensivist on inotropes and postoperative care following pediatric heart surgery: an international survey and systematic review of the literature. World J Pediatr Congenit Heart Surg 9:10–21
Rosenthal D, Chrisant MR, Edens E et al (2004) International Society for Heart and Lung Transplantation: practice guidelines for management of heart failure in children. J Heart Lung Transplant 23(12):1313–1333
Ross RD, Bollinger RO, Pinsky WW (1992) Grading the severity of congestive heart failure in infants. Pediatr Cardiol 13:72–75
Tume SC, Goldberg J, Molossi S, Bronicki RA (2016) Pharmacologic approach to heart failure in children. Curr Cardiol Rev 12(2):117–120
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, Drazner MH, Filippatos GS, Fonarow GC, Givertz MM, Hollenberg SM, Lindenfeld J, Masoudi FA, McBride PE, Peterson PN, Stevenson LW, Westlake C (2017) 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the heart failure society of America. J Am Coll Cardiol 70:776–803
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this entry
Cite this entry
Kramer, H.H. (2019). Herzinsuffizienz und Hypoxämie bei Kindern und Jugendlichen. In: Hoffmann, G., Lentze, M., Spranger, J., Zepp, F., Berner, R. (eds) Pädiatrie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54671-6_200-2
Download citation
DOI: https://doi.org/10.1007/978-3-642-54671-6_200-2
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-54671-6
Online ISBN: 978-3-642-54671-6
eBook Packages: Springer Referenz Medizin
Publish with us
Chapter history
-
Latest
Herzinsuffizienz und Hypoxämie bei Kindern und Jugendlichen- Published:
- 08 May 2019
DOI: https://doi.org/10.1007/978-3-642-54671-6_200-2
-
Original
Herzinsuffizienz und Hypoxämie bei Kindern und Jugendlichen- Published:
- 31 March 2015
DOI: https://doi.org/10.1007/978-3-642-54671-6_200-1